There are several large players in the world of animal health, including Idexx Labs and Zoetis , but Heska (NASDAQ: HSKA) , a much smaller competitor, has outperformed its larger peers in terms of stock price appreciation over the past year.
Heska is an animal health company focused on providing diagnostic tools used by veterinarians. These are the types of tests that help analyze blood and urine samples to detect diseases in dogs and cats. The company has seen its stock skyrocket recently due to a boom in the pet healthcare market overall as more people adopt pets and visit veterinary clinics. Heska has also taken several interesting steps to set itself up for continued growth in the future, making the stock potentially lucrative for long-term shareholders.
For further details see:
Heska Is Up More Than 70% in 6 Months -- Is It Too Late to Buy the Stock?